Analyst Report
The latest news about Analyst Report: headlines, AI summaries and the full story from every source.
- Evercore ISI Upgrades Procter & Gamble with Higher Price Target
- KeyBanc Upgrades Airbnb Stock, Sets New Price Target
- Citi Downgrades Moderna to Sell Amid Concerns Over Stock Valuation
- Bank of America Downgrades Nike to Underperform, Citing Rising Risks and Earnings Concerns
- Lucid Group Shares Rise Over 5% After Analyst Report Highlights Partnership Deal
- Evercore Upgrades Ciena Stock to 'Outperform' with Raised Price Target
- HSBC Downgrades Netflix as YouTube Gains Ground
- Wells Fargo Downgrades Netflix Stock to Underweight, Cuts Price Target
- Guggenheim Analyst Downgrades LYFT Stock Amid Cooling Demand
- Bernstein Identifies CoreWeave as Most Exposed to AI Training Slowdown
- Frequency Electronics Downgraded to Hold by Freedom Broker Despite Strong Financial Performance
- Morgan Stanley Upgrades Synopsys Stock to 'Overweight'
- PVH Reports Strong Q2 Earnings Despite Sales Decline
- Morgan Stanley Raises Price Target on Salesforce Amid Strong Earnings and New AI Partnership
- Wells Fargo Raises Price Target on Snowflake to $500 Amid AI Growth Potential
- Morgan Stanley Raises GE Vernova Stock Target Amid Record Orders and Guidance Hike
- Deutsche Bank Downgrades Monster Beverage Stock to Hold Amid Valuation Concerns
- BTIG Downgrades TripAdvisor to Neutral Amid AI Risks and Strategic Uncertainty
- FuelCell Energy Rises While Bloom Energy Falls Amid Fuel-Cell Sector Divergence
- Deutsche Bank Downgrades Monster Beverage from Buy to Hold
- Truist Analyst Downgrades Lululemon Stock Amid Declining Consumer Interest and Momentum
- Truist Upgrades Global-E Online (GLBE) to Buy
- Broadcom Stock Rises Amid Capital Shift Toward Hardware and Analyst Commentary
- Deckers Outdoor Shares Rise Following Jefferies Upgrade to Buy
- Arete Research Downgrades Paramount Stock Amid Concerns Over Debt Load
- UBS Analyst Forecasts 3% App Store Growth for Apple in June 2026 Quarter
- Edgewise Therapeutics Price Target Raised to $59 Following Positive HCM Trial Data
- Evercore ISI Downgrades Nike Stock Amid Concerns Over Turnaround Progress
- KeyBanc Downgrades Nike Amid Concerns Over Turnaround Progress
- Susquehanna Raises Price Target on Broadcom Ahead of Earnings Despite Lowering AI Revenue Estimate
- Susquehanna Raises Price Target on Broadcom Ahead of Earnings Despite Lowering AI Revenue Forecast
- UBS Maintains Buy Rating on FedEx Ahead of Freight Spin-Off
- Jefferies Raises Price Target for Core Scientific Amid Strong AI Infrastructure Demand
- Analyst Adjusts Price Target for Nvidia Ahead of Earnings
- Bernstein Lowers Price Target on L3 Harris Technologies (LHX) Despite Strong Q1 Earnings
- Jefferies Upgrades Devon Energy to Buy, Citing Merger Synergies and Valuation
- Stifel Upgrades Shake Shack to Buy Amid Earnings-Driven Sell-Off
- Wells Fargo Upgrades Alcoa as Analyst Sees Further Stock Gains Amid Rising Aluminum Prices
- Morgan Stanley Adjusts KLA Corp Stock Price Target Amid Mixed Outlook
- Wall Street Raises Qualcomm's Price Target to $160 Amid AI Growth Expectations
- Oppenheimer Initiates Coverage of Palantir with Outperform Rating Ahead of Q1 Earnings
- Bank of America Raises Price Target for Dell Technologies Amid Growing AI Infrastructure Demand
- Plug Power Stock Surges Amid Analyst Upgrade and Renewable Energy Momentum
- Analysts Reduce Price Target for Iren Limited Despite AI Expansion
- Redburn Upgrades SNAP Stock to 'Buy' with Higher Price Target
- Wall Street Upgrades Snap to Buy, Raising Price Target to $10
- Roth Capital Maintains Buy Rating for Applied Digital (APLD) Amid Major Infrastructure Deal
- Daiwa Downgrades Abbott Laboratories, Cuts Price Target
- Intel Set to Report Q1 Earnings Amid Analyst Watchfulness
- Tesla Receives Analyst Support Following Strong Q1 Earnings and AI Strategy